Purchase Order 75N93022P00476

The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $345,333 firm fixed price purchase order to Genewiz, LLC for whole genome sequencing services using 90 human induced pluripotent stem cell samples. The solicitation sought these sequencing services to be performed within 45 days of sample receipt in September 2020. Genewiz will conduct the work at its facility in South Plainfield, New Jersey as the incumbent...

Genscript USA Incorporated will provide gene synthesis services to the National Institutes of Health's National Institute of Allergy and Infectious Diseases under a $12,500 firm fixed price purchase order. The one-year contract was awarded on September 14, 2023 and runs through September 13, 2024. Genscript will deliver the gene synthesis work from its location in Piscataway, New Jersey. No subcontractors or additional context were provided regarding the specific research being supported under...

Centrillion Technologies, Inc. was awarded a delivery order contract on June 27, 2017, for metagenomic sequencing services utilizing HiSeq Rapid 2x250 technology to process 18 samples. The contract, with a ceiling value of $24,895.00, is structured as a firm fixed-price delivery order and carries no set-aside designation. The work is being performed in Palo Alto, California, with an ultimate completion date of November 30, 2018. The funding source is identified as a civilian federal agency...

The Department of Agriculture Agricultural Research Service awarded a firm fixed price purchase order contract valued at twenty-four thousand nine hundred sixty dollars to Psomagen Inc. to sequence ninety-six RNA samples of fish. Under the contract, Psomagen will perform gene library creation and sequencing services for each sample, including library creation for Illumina sequencing using poly(A) selection and Illumina high-throughput sequencing at a depth of twenty-five million paired-end reads...

This contract, awarded by the Centers for Disease Control and Prevention (CDC) to Genewiz, LLC, is for the rapid synthesis of gene sequences for the development of COVID-19 vaccine candidate viruses. The $248,947.75 firm fixed price purchase order does not have a set-aside designation. Genewiz, a global contract research organization, has provided DNA and RNA sequencing, gene synthesis, cloning, and other genomic services to various federal agencies through IDIQ contracts and other vehicles....

The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $702,500 firm-fixed-price contract to Genscript USA Inc. to provide gene synthesis services in support of COVID-19 testing. Under the contract, Genscript will synthesize 150 genes and conduct 150 mutagenesis and 250 express cloning projects, as well as prepare 425 plasmids. These products and services will support the testing of COVID-19 antibody therapeutics, convalescent plasma, and vaccines...

This is a $24,900 firm fixed-price purchase order awarded by the Shared Services Center of a civilian federal agency to Novogene Corporation Inc., a minority-owned small business headquartered in Sacramento, California. The contract is for the performance of metagenomics sequencing on 110 samples, with a 2x150bp sequencing depth and a target of 30 million reads per sample. The award does not utilize a set-aside designation. Novogene Corporation specializes in providing advanced genomic...

This is a firm-fixed-price purchase order contract awarded by the Southeast Area of a civilian federal agency to Eurofins Genomics LLC, a for-profit manufacturer, to provide DNA Sanger sequencing services for 600 samples/reactions. The contract has a ceiling value of $3,600.00 and a completion date of July 29, 2022. Eurofins Genomics is an experienced federal contractor, having received numerous awards from agencies like the Department of Health and Human Services, Department of Defense, and...

The U.S. government awarded a delivery order valued at $64,752 to Life Technologies Corporation (operating as Thermo Fisher Scientific) on March 13, 2026, for the procurement of a Sanger Sequencer—SeqStudio with SmartStart system. The award is a firm fixed price delivery order with no set-aside designation, with an ultimate completion date of May 13, 2026. The equipment will be delivered to Athens, Georgia. Life Technologies Corporation is a leading manufacturer of scientific instruments,...

This $438,600 firm fixed price purchase order was awarded by the Department of Health and Human Services Food and Drug Administration to Pacific Biosciences of California, Inc. to deliver a SEQUEL IIE SYSTEM long-read DNA/RNA sequencing machine. The solicitation sought quotes for a turnkey sequencing solution to detect pathogen variants, access previously inaccessible genomic regions, and advance genetic research at the FDA's Center for Biologics Evaluation and Research Division of Cell and Gene...